Inify Laboratories

Less than 1K followers

INIFY

Euronext Growth Oslo

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Inify Laboratories provides cancer diagnostics through pathology laboratory services. The company uses a digital, standardized workflow for response times and quality assurance, initially within prostate diagnostics. The customers mainly consist of laboratories and hospitals. Inify Laboratories was founded in 2022 and has its headquarters in Stockholm.

Market cap

-

Turnover

-

Revenue

13.5M

EBIT %

-403.58 %

P/E

-

Dividend yield-%

-

Financial calendar

30.4

2025

Interim report Q1'25

20.5

2025

General meeting '25

27.8

2025

Interim report Q2'25

ShowingAll content types

Regulatory press release2/26/2025, 7:00 AM

Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion

Inify Laboratories

Regulatory press release2/26/2025, 7:00 AM

Inify Laboratories AB: Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion

Inify Laboratories

Regulatory press release2/14/2025, 1:01 PM

Inify Laboratories - New share capital registered

Inify Laboratories

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release2/14/2025, 1:01 PM

Inify Laboratories AB: Inify Laboratories - New share capital registered

Inify Laboratories

Regulatory press release2/12/2025, 1:45 PM

Inify Laboratories - Resolution to issue new shares in Private Placement and Subsequent Offering

Inify Laboratories

Regulatory press release2/12/2025, 1:45 PM

Inify Laboratories AB: Inify Laboratories - Resolution to issue new shares in Private Placement and Subsequent Offering

Inify Laboratories

Regulatory press release1/30/2025, 10:57 AM

Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release1/30/2025, 10:57 AM

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release1/24/2025, 7:00 PM

Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release1/24/2025, 7:00 PM

Inify Laboratories AB: Inify Laboratories - mandatory notification of trade

Inify Laboratories

Regulatory press release1/23/2025, 7:49 PM

Inify Laboratories - Final results of the Subsequent Offering

Inify Laboratories

Regulatory press release1/23/2025, 7:49 PM

Inify Laboratories AB: Inify Laboratories - Final results of the Subsequent Offering

Inify Laboratories

Regulatory press release1/23/2025, 6:30 AM

Inify Laboratories - Last day of the subscription period in the Subsequent Offering

Inify Laboratories

Regulatory press release1/23/2025, 6:30 AM

Inify Laboratories AB: Inify Laboratories - Last day of the subscription period in the Subsequent Offering

Inify Laboratories

Regulatory press release1/9/2025, 6:30 AM

Inify Laboratories - Commencement of subscription period for Subsequent Offering

Inify Laboratories

Regulatory press release1/9/2025, 6:30 AM

Inify Laboratories AB: Inify Laboratories - Commencement of subscription period for Subsequent Offering

Inify Laboratories

Regulatory press release1/8/2025, 10:31 AM

INIFY: Inify Laboratories enter into agreement with Swedish region

Inify Laboratories

Press release1/8/2025, 10:31 AM

Inify Laboratories AB: Inify Laboratories enter into agreement with Swedish region

Inify Laboratories

Regulatory press release1/7/2025, 4:05 PM

Inify Laboratories - Registration of prospectus and upcoming launch of Subsequent Offering

Inify Laboratories

Regulatory press release1/7/2025, 4:04 PM

Inify Laboratories AB: Inify Laboratories - Registration of prospectus and upcoming launch of Subsequent Offering

Inify Laboratories

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.